Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thileepan Naren

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 1, 2023
Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunitiesJordan Kirby, Thileepan Naren
Australian Journal of General Practice|April 8, 2022
Aboriginal communities need to be at the forefront of the COVID-19 vaccination campaignThileepan Naren, Dallas Widdicombe
The Medical Journal of Australia|March 8, 2023
Kamini: an underappreciated cause of opioid dependenceThileepan Naren, Jon Cook
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|March 6, 2024
Direct induction onto high-dose long-acting injectable buprenorphine: A case seriesThileepan Naren, Jon Cook, Paul MacCartney
Australian Health Review : a Publication of the Australian Hospital Association|November 24, 2022
Enhancing person-centred care and access to primary care for Aboriginal and Torres Strait Islander peoplesBryce Brickley, Jaydene Burzacott, Thileepan Naren
Drug and Alcohol Review|June 17, 2022
Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapyThileepan Naren, David Silkoff, Marcus Forsythe, et al.
Drug and Alcohol Review|July 7, 2024
Re-examining mandatory drug testing in Australian prisonsJocelyn Chan, Mark Stoové, Jon Cook, et al.
Drug and Alcohol Review|February 26, 2024
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphineThileepan Naren, Jon Cook, Paul MacCartney, et al.
Internal Medicine Journal|April 20, 2026
Case for caution in expanding attention deficit hyperactivity disorder prescribingMax Hankin, Anthony Hew, Shalini Arunogiri, et al.
Drug and Alcohol Review|May 26, 2023
People who use drugs in hospital settings: 'Moving towards a person-centred harm reduction model'Thileepan Naren, Paul MacCartney, Sione Crawford, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 1, 2023
Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunitiesJordan Kirby, Thileepan Naren
Australian Journal of General Practice|April 8, 2022
Aboriginal communities need to be at the forefront of the COVID-19 vaccination campaignThileepan Naren, Dallas Widdicombe
The Medical Journal of Australia|March 8, 2023
Kamini: an underappreciated cause of opioid dependenceThileepan Naren, Jon Cook
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|March 6, 2024
Direct induction onto high-dose long-acting injectable buprenorphine: A case seriesThileepan Naren, Jon Cook, Paul MacCartney
Australian Health Review : a Publication of the Australian Hospital Association|November 24, 2022
Enhancing person-centred care and access to primary care for Aboriginal and Torres Strait Islander peoplesBryce Brickley, Jaydene Burzacott, Thileepan Naren
Drug and Alcohol Review|June 17, 2022
Case series on treatment of dependence to Kamini Vidrawan Ras with opioid substitution therapyThileepan Naren, David Silkoff, Marcus Forsythe, et al.
Drug and Alcohol Review|July 7, 2024
Re-examining mandatory drug testing in Australian prisonsJocelyn Chan, Mark Stoové, Jon Cook, et al.
Drug and Alcohol Review|February 26, 2024
Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphineThileepan Naren, Jon Cook, Paul MacCartney, et al.
Internal Medicine Journal|April 20, 2026
Case for caution in expanding attention deficit hyperactivity disorder prescribingMax Hankin, Anthony Hew, Shalini Arunogiri, et al.
Drug and Alcohol Review|May 26, 2023
People who use drugs in hospital settings: 'Moving towards a person-centred harm reduction model'Thileepan Naren, Paul MacCartney, Sione Crawford, et al.
Pageof 3